We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+11.67%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$9.22B
AUM Growth
+$331M
(+3.7%)
Cap. Flow
-$371M
Cap. Flow
% of AUM
-4.02%
Top 10 Holdings %
Top 10 Hldgs %
56.36%
Holding
1,043
New
155
Increased
182
Reduced
486
Closed
210
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hess Midstream
HESM
|
+$149M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$105M |
| 3 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$97.9M |
| 4 |
MPLX
MPLX
|
+$74.6M |
| 5 |
DCP
DCP Midstream, LP
DCP
|
+$63.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Western Midstream Partners
WES
|
+$541M |
| 2 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
+$338M |
| 3 |
Williams Companies
WMB
|
+$35.8M |
| 4 |
ExxonMobil
XOM
|
+$29.6M |
| 5 |
Verizon
VZ
|
+$25.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 65.72% |
| 2 | Technology | 5.09% |
| 3 | Consumer Discretionary | 3.8% |
| 4 | Healthcare | 3.45% |
| 5 | Industrials | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Sabra Healthcare REIT
SBRA
$5.63B
| $1.13M | 0.01% |
75,602
-11,641
| -13% | -$159K |
|
302
Omega Healthcare
OHI
$15.3B
| $1.1M | 0.01% |
35,461
-5,070
| -13% | -$150K |
|
303
National Health Investors
NHI
$3.86B
| $1.09M | 0.01% |
18,418
-2,834
| -13% | -$161K |
|
304
Marriott International
MAR
$100B
| $1.08M | 0.01% |
6,151
+2,695
| +78% | +$448K |
|
|
IMGN
305
DELISTED
Immunogen Inc
IMGN
| $1.08M | 0.01% |
226,649
-21,110
| -9% | -$117K |
|
306
Crinetics Pharmaceuticals
CRNX
$8.87B
| $1.07M | 0.01% |
48,815
-6,149
| -11% | -$124K |
|
307
Rocket Pharmaceuticals
RCKT
$359M
| $1.05M | 0.01% |
66,294
-8,283
| -11% | -$143K |
|
|
RC
308
Ready Capital
RC
$270M
| $1.03M | 0.01% |
68,749
-8,701
| -11% | -$130K |
|
309
SiriusXM
SIRI
$10.6B
| $1.03M | 0.01% |
15,620
-2,529
| -14% | -$159K |
|
310
Coherus Oncology
CHRS
$228M
| $1.02M | 0.01% |
79,420
-9,439
| -11% | -$120K |
|
311
Organogenesis Holdings
ORGO
$332M
| $1.01M | 0.01% |
132,342
-41,994
| -24% | -$325K |
|
|
PMT
312
PennyMac Mortgage Investment
PMT
$845M
| $1M | 0.01% |
59,521
-7,536
| -11% | -$126K |
|
313
Advanced Micro Devices
AMD
$784B
| $1M | 0.01% |
9,140
-1,256
| -12% | -$150K |
|
314
Arcutis Biotherapeutics
ARQT
$3.5B
| $997K | 0.01% |
51,783
-6,420
| -11% | -$109K |
|
315
Syndax Pharmaceuticals
SNDX
$1.86B
| $983K | 0.01% |
56,536
-1,643
| -3% | -$27.7K |
|
316
Anavex Life Sciences
AVXL
$232M
| $964K | 0.01% |
78,286
-9,686
| -11% | -$119K |
|
317
MannKind Corp
MNKD
$1.26B
| $952K | 0.01% |
258,787
-31,997
| -11% | -$117K |
|
318
Annaly Capital Management
NLY
$17B
| $923K | 0.01% |
32,782
-4,150
| -11% | -$123K |
|
319
Blue Owl Capital
OBDC
$5.42B
| $909K | 0.01% |
+61,500
| New | +$901K |
|
320
Cintas
CTAS
$84.5B
| $900K | 0.01% |
8,468
+3,340
| +65% | +$325K |
|
321
The Mosaic Company
MOS
$7.02B
| $894K | 0.01% |
13,455
-5,372
| -29% | -$269K |
|
322
Atara Biotherapeutics
ATRA
$71.4M
| $889K | 0.01% |
3,827
-266
| -6% | -$84.7K |
|
|
KDNY
323
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $889K | 0.01% |
54,364
-6,857
| -11% | -$93.2K |
|
324
Estee Lauder
EL
$29.7B
| $884K | 0.01% |
3,248
+236
| +8% | +$71K |
|
|
RTLR
325
DELISTED
Rattler Midstream LP Common Units
RTLR
| $878K | 0.01% |
62,815
-4,168
| -6% | -$54.1K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, ALPS Advisors held 1,043 positions worth $9.22B, up 3.7% from $8.89B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
ALPS Advisors withdrew a net $371M in Q1 2022, closing 210 positions and reducing 486 holdings. Its most notable exit was Western Midstream Partners, an estimated $541M position sold in full.
By sector, the portfolio is most concentrated in Energy at 66% of assets, up from 59% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, ALPS Advisors opened a new position in Lucid Motors worth $40.8M.
- ALPS Advisors's largest Q1 2022 buy was Lucid Motors: 160,553 shares worth $40.8M.
- ALPS Advisors added most to Hess Midstream in Q1 2022, an estimated $149M increase.
- ALPS Advisors's biggest Q1 2022 reduction was Williams Companies, cutting an estimated $35.8M.
- ALPS Advisors fully exited Western Midstream Partners in Q1 2022, selling an estimated $541M.
- ALPS Advisors's ten largest holdings make up 56% of its $9.22B portfolio in Q1 2022.
- ALPS Advisors opened 155 new positions and closed 210 in Q1 2022.
- ALPS Advisors's portfolio value rose 3.7% quarter-over-quarter to $9.22B.
Based on ALPS Advisors's 13F filing for Q1 2022, filed 16 May 2022.